Gotham Asset Management »

Summit Therapeutics shares owned by Gotham Asset Management

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Gotham Asset Management from 13F filings

Historical chart of Gotham Asset Management investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Gotham Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Gotham Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $282k 16k 17.85
2024-09-30 $348k 16k 21.90
2024-06-30 $152k 20k 7.80